org placeholder image

Mark Erlander

Chief Scientific Officer at Biotheranostics, Inc., A Hologic Company

  • LinkedIn
map
BIOTHERANOSTICS, INC., A HOLOGIC COMPANY

BIOTHERANOSTICS, INC., A HOLOGIC COMPANY

  • description Description
    Biotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 1 Billion and Over
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Biotheranostics, Inc., A Hologic Company Org Chart and Mapping

Employees

Alisha Crawford

Oncology Account Executive

Gail Sloan

Senior Financial Executive, CFO

Liu Tang

Sr. Quality Assurance Specialist

Rocio Guzman

Patient Services Supervisor

Yi Zhang

Sr. Director of Biostatistics

Frequently Asked Questions Regarding Mark Erlander

Answer: Mark Erlander works for Biotheranostics, Inc., A Hologic Company as Chief Scientific Officer

Answer: Mark Erlander’s role in Biotheranostics, Inc., A Hologic Company is Chief Scientific Officer

Answer: Mark Erlander's email address is m***@gmail.com

Answer: Mark Erlander's business email address is m****@biotheranostics.com

Answer: Mark Erlander’s direct phone number is (***)-***-****

Answer: Mark Erlander works in the industry of: Hospital & Health Care

Answer: Mark Erlander works Biotheranostics, Inc., A Hologic Company located at 250 Campus Dr, San Diego, California, 01752, United States

Answer: Biotheranostics, Inc., A Hologic Company's Chief Scientific Officer is Mark Erlander

Answer: Mark Erlander contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@biotheranostics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access